Psychedelic Compounds Reopen Motor Skill Learning Window
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods fail to effectively reopen or extend the critical window for relearning motor skills after central nervous system injuries, leading to limited motor function improvement once neuroplasticity decreases.
Innovation Solution
Administration of psychedelic, empathogenic, or dissociative compounds, such as LSD, psilocybin, MDMA, or ketamine, in conjunction with motor skill restoration therapies like physical, occupational, or speech therapy, to reopen or extend the critical window for motor skill relearning.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If motor skill restoration therapy is administered after the critical window closes, then motor function improvement is limited, but continued therapy administration is required
Solution Approach 1:
The patent applies parameter changes by using psychedelic compounds to alter the neuroplasticity state of the brain. These compounds modify physiological parameters (neurotransmitter release, receptor sensitivity) to reopen or extend the critical window, enabling motor skill restoration therapy to be effective beyond the traditional time limit. This directly resolves the contradiction by changing the biological state to restore therapeutic effectiveness.
2Adaptability or versatility
If psychedelic compounds are administered to reopen the critical window, then motor skill relearning capability is restored, but new therapeutic interventions are required
Solution Approach 1:
The patent uses psychedelic compounds as intermediary substances that mediate between the injury state and the therapeutic intervention. These compounds act as a bridge that temporarily restores neuroplasticity, allowing standard motor skill restoration therapy to become effective again. The psychedelic compound is the intermediary that enables the connection between injury recovery and therapy effectiveness.
3Productivity
If motor skill restoration therapy is administered continuously, then motor function improvement is maximized during the critical window, but therapy effectiveness decreases after the window closes
Solution Approach 1:
The patent implements periodic action by administering psychedelic compounds at specific intervals to reopen the critical window. Rather than continuous therapy administration, the approach uses periodic psychedelic intervention followed by motor skill restoration therapy. This periodic reopening of plasticity maintains therapy effectiveness over extended periods, resolving the contradiction between continuous therapy need and decreasing effectiveness.
Data Source
AI summary
Methods of improving motor function in subjects diagnosed with a central nervous system injury are contemplated as including an administration of a psychedelic, empathogenic, or dissociative compound in a pharmaceutically effective amount followed by administration of a motor skill restoration therapy. The psychedelic, empathogenic, or dissociative compound may be administered to a subject that has been determined to be therapy refractive with a chronic central nervous system injury, to a subject with a subacute central nervous system injury sustained within 7 days and 6 months prior, or to a subject with an acute central nervous system injury sustained within the past 7 days. Such methods may be seen improve motor function in the subjects.